Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Magnesium and Strontium-Doped Bioglass Nanoparticles as a Novel Formulation: Advancing Osteoconductivity and Enhancing Bone Healing Potential

Aliabadi MM., Jahani A., Moradi A., Jirofti N.

Animal Study on Face & Skin, published in Small Sci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Small Sci (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42112472
PMCID
PMC13154918
DOI
10.1002/smsc.70263

Abstract (original English)

Bioglass has gained significant attention in bone tissue engineering (BTE) due to its excellent bioactivity, osteoconductivity, and biodegradability. Recent advancements involve doping magnesium (Mg) and strontium (Sr) to enhance its osteogenic properties. This study aimed to synthesize Sr/Mg-doped 58S bioglass nanoparticles via the sol-gel method, incorporating 58% SiO 2 , 37% CaO, 2% P 2 O 5 , 2% MgO, and 1% SrO, and to evaluate their potential for bone regeneration. The bioglass properties, including surface morphology, elemental composition, and particle size distribution, were characterized to assess their structural properties. Cell viability was evaluated over 7 days using the Resazurin assay on L929 fibroblast cells, while in vivo bone regeneration potential was assessed in rabbit skull defect models. The bioglass nanoparticles showed uniform nanoscale morphology with effective Sr and Mg incorporation. Cell viability assays demonstrated high compatibility, with no significant cytotoxicity over 7 days. In vivo results demonstrated a significant enhancement in bone formation within rabbit calvarial defects implanted with Sr/Mg-doped bioglass (60.24 ± 2.88%) compared to the undoped bioglass group (45.80 ± 4.39%) and the control group (45.81 ± 6.01%) at 28 days post-implantation. Sr/Mg-doped 58S bioglass nanoparticles demonstrated enhanced biocompatibility and sustained ion

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research